Inmagene Biopharmaceuticals

Inmagene Biopharmaceuticals

Inmagene is a clinical-stage biotech company developing innovative and differentiated therapies for immunological and inflammatory diseases. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
AUD618—927m (Dealroom.co estimates Jun 2021.)
San Diego California (HQ)
Authorizing premium user...